MỘT SỐ ĐẶC ĐIỂM LÂM SÀNG RỐI LOẠN LO ÂU VÀ TRẦM CẢM Ở BỆNH NHÂN COVID-19

Vũ Ngọc Ninh Đinh; Trần Khang Đặng; Văn Chân Đặng; Minh Dũng Nguyễn; Trọng Nghĩa Nguyễn; Văn Thuỷ Nguyễn; Thanh Bình Phạm; Thị Bích Vân Phạm

doi:10.59354/ydth175.2022.39

Keywords:

Anxiety disorder, depression, COVID-19 pandemic, DASS-21

Abstract

Objectives: To describe clinical characteristics of anxiety disorder and depression in COVID-19 patients.

Subjects and methods: Cross description study on 117 COVID-19 patients treating at 175 Military Hospital.

Results: The prevalence of anxiety disorder and depression in COVID-19 patients are 26,5% (95%CI 19,2-35,4%) and 6,0% (95%CI 2,8-12,1%), respectively. The most common of anxiety symptoms are sleep disturbance (44%), restlessness or feeling on edge (38,5%), being easily fatigued (35,9%). In depressive patients, insomnia or hypersomnia is the most frequency symptom at 41,9%.

Conclusion: In COVID-19 patients, the most common anxiety symptom is sleep disturbance, following by restlessness and being easily fatigued; in depression, insomnia or hypersomnia account for the highest rate.

References

Lương Công Thức. et al. (2021), “Nghiên cứu đặc điểm rối loạn trầm cảm, lo âu và stress ở bệnh nhân COVID-19”, Tạp chí Y dược học Quân sự. Số đặc biệt chuyên đề về COVID-19, pp. 257-264.

Bo H. X. et al. (2021), “Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China”, Psychol Med. 51 (6), pp. 1052-1053.

Chen N. et al. (2020), “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study”, Lancet. 395 (10223), pp. 507-513.

Guo Q. et al. (2020), “Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study”, Brain Behav Immun. 88, pp. 17-27.

Huang Y. et al. (2020), “Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey”, Psychiatry Res. 288, pp. 112954.

Kong W. H. et al. (2020), “Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity”, Virol Sin. 35 (6), pp. 752-757.

Kong X. et al. (2020), “Prevalence and Factors Associated with Depression and Anxiety of Hospitalized Patients with COVID-19”, medRxiv, pp. 2020.2003.2024.20043075.

Trevisan C. et al. (2021), “Age- Related Changes in Clinical Presentation of Covid-19: the EPICOVID19 Web-Based Survey”, Eur J Intern Med. 86, pp. 41-47.

Dai L-L. et al. (2020), “Anxiety and depressive symptoms among COVID-19 patients in Jianghan Fangcang Shelter Hospital in Wuhan, China”, PLoS ONE. 15 (8), pp. 1-11.

Deng J. et al. (2020), “The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis”, Ann. N.Y. Acad. Sci., pp. 1-22.